Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Recurrence 1 Pancreatic Neoplasms 1 Oligometastatic Lung Adenocarcinoma 1 Neoplasm Metastasis 1 NSCLC 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 EGFR Mutation Positive Non-small Cell Lung Cancer 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Surveys and Questionnaires 9 Standard of Care 5 Endoscopic Mucosal Resection 5 Educational Status 5 Blood Specimen Collection 5 Diet Therapy 3 Referral and Consultation 2 Quality of Life 2 Practice Guidelines as Topic 2 Palliative Care 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Control Groups 2 Aprepitant 2 Acceptance and Commitment Therapy 2 vandetanib 1 fosaprepitant 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Weights and Measures 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surgical Instruments 1 Sunitinib 1 Sorafenib 1 Sampling Studies 1 Restraint, Physical 1 Remote Patient Monitoring 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Gastrointestinal Neoplasms × Erlotinib Hydrochloride × Clear all

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡